BUY
₹5,028
₹5,265.3
₹6,357
26.43%
In its August 10, 2026 Q1FY27 result update on Fine Organic Industries, Prabhudas Lilladher maintained its BUY rating and raised the target price to Rs 6,357 from Rs 6,001. The report was prepared by Swarnendu Bhushan, Saurabh Ahire and Tejas Kadam.
The broker's central investment thesis is that the ongoing greenfield SEZ project and a proposed US manufacturing facility can be important long-term growth catalysts. At the report price, Fine Organic traded at about 28x FY28E EPS; PL values the stock at 35x FY28E EPS for its Rs 6,357 target price.
Fine Organic reported a strong Q1FY27. Consolidated revenue was Rs 6,942 million, up 18.0 per cent year on year and 11.0 per cent quarter on quarter. Revenue exceeded PL's Rs 5,931 million estimate by 17.0 per cent and consensus of Rs 6,200 million. Export demand improved while domestic demand was steady; domestic and export sales accounted for 40 per cent and 60 per cent of quarterly revenue respectively.
EBITDA was Rs 1,760 million, up 42.4 per cent year on year and 35.5 per cent quarter on quarter. It was 51.9 per cent above PL's estimate and higher than consensus of Rs 1,284 million. EBITDA margin expanded to 25.3 per cent from 21.0 per cent in Q1FY26 and 20.8 per cent in Q4FY26. PL attributes the sequential margin expansion primarily to higher realisations.
Reported PAT was Rs 1,381 million, up 17.9 per cent year on year and 17.6 per cent quarter on quarter, compared with PL's Rs 935 million estimate. Profit after tax before the share of loss from the joint venture was Rs 1,401 million; the Thailand joint venture's share of loss was Rs 19 million. Raw-material prices remained elevated in Q1FY27 compared with FY26, although the sequential increase was marginal. This cost backdrop remains a relevant observation alongside the margin recovery.
| Q1FY27 metric | Reported | Year-on-year change | Quarter-on-quarter change | PL estimate / consensus |
|---|---|---|---|---|
| Revenue | Rs 6,942 million | 18.0% | 11.0% | PL: Rs 5,931 million; consensus: Rs 6,200 million |
| EBITDA | Rs 1,760 million | 42.4% | 35.5% | PL: 51.9% below reported; consensus: Rs 1,284 million |
| EBITDA margin | 25.3% | 21.0% in Q1FY26 | 20.8% in Q4FY26 | Expansion attributed primarily to higher realisations |
| Reported PAT | Rs 1,381 million | 17.9% | 17.6% | PL estimate: Rs 935 million |
The greenfield SEZ project entails capex of Rs 7,000–7,500 million and is expected to begin commercial operations in FY28. PL estimates peak revenue potential of about Rs 26,000 million, assuming asset turnover of 3.5x. The broker expects the project to contribute meaningfully to revenue from FY28/FY29 onwards.
Fine Organic acquired about 159.9 acres of land in the US in June 2025 and expects to finalise the capex plan for its proposed US manufacturing plant by Q2FY27. During Q1FY27, the company infused approximately Rs 61.7 million of equity into its Thailand joint venture and about Rs 4.9 million into its UAE subsidiary.
Fine Organic received a final Rs 43.5 million settlement in July 2026 for property damage and inventory losses from the Badlapur plant fire, following Rs 18.0 million of interim settlements.
PL raised FY27E and FY28E sales estimates by 3.8 per cent each to Rs 25,787 million and Rs 29,655 million. EBITDA estimates rose 15.0 per cent and 11.1 per cent to Rs 5,779 million and Rs 7,121 million, while EPS estimates rose 13.3 per cent and 8.9 per cent to Rs 149.9 and Rs 181.6.
| Metric | FY27E | FY28E |
|---|---|---|
| Revenue | Rs 25,787 million; growth of 9.0% | Rs 29,655 million; growth of 15.0% |
| EBITDA | Rs 5,779 million | Rs 7,121 million |
| EBITDA margin | 22.4% | 24.0% |
| PAT | Rs 4,597 million | Rs 5,569 million |
| EPS | Rs 149.9 | Rs 181.6 |
PL expects exports to reach 60 per cent of revenue in FY28E and forecasts a PAT CAGR of 16 per cent over FY26–28E. The estimates and valuation reflect the broker's expectation that the SEZ project and proposed US manufacturing facility will support longer-term, export-led growth.
Disclaimer: This is a summary of a research report published by the broker/research house identified above. The views, recommendations, target prices and estimates are those of the respective broker and do not represent DSIJ investment advice. The summary may be AI-assisted, hence please refer to the original report for complete details, disclosures and risks.
Copyright 2026 by DSIJ Wealth Advisory Pvt. Ltd. (Formerly Known as DSIJ Pvt. Ltd.)